News

Health system redesigns its imaging management structure around modalities, rather than operating lines

At Atlanta-based Emory Healthcare, this fractured approach had resulted in uneven technologist staffing, variable asset utilization and scheduling, and diverging modality quality and safety practices.

Radiopharmaceutical therapy use has increased 2,000% among Medicare population

Interventional and diagnostic radiologists are leading the way in this surge, accounting for about 45% of IV RPT administrations, according to Medicare Part B claims.

Moderna, FDA reach compromise to accelerate approval of mRNA flu vaccine

The dispute centered around the pharmaceutical company's request for the shot to be approved for those aged 65 and over, a demographic the FDA argued was not properly represented in a 40,000-person clinical study. The company has agreed to perform additional research after the shot goes to market, having appeased regulators with safety data.

Federal court strikes down FTC mergers and acquisitions reporting rule

A U.S. District Court in Texas ruled that the agency overstepped its regulatory authority in passing the 2024 Biden-era reporting requirement, which would require stakeholders to spend more than 100 hours filling out a long form to give the agency more oversight of transactions.

Paramedics, flight nurses become experts in trauma care by hands-on experience, not long careers per se

EMS colleagues with many years on the job but not much direct trauma exposure set the stage for suboptimal patient outcomes.

'Revolutionary' mobile imaging pilot program excels at preventing unnecessary ED visits

A pilot project involving portable imaging in patients’ homes following injuries has been a game changer for one community.

Statin labeling should be revised with updated warnings, meta-analysis confirms

Researchers explored data from more than 123,000 patients, noting that dozens of the adverse complications included on current labels can safely be removed.

Esperion Therapeutics Inc. has filed patent infringement lawsuits against eight generic drug makers for filing U.S. Food and Drug Administration (FDA) abbreviated new drug applications (ANDA) to make generic versions of its successful bempedoic acid (Nexletol).

Esperion settles another lawsuit to keep generic versions of popular drug off shelves

As soon as Esperion Therapeutics gained FDA clearance for Nexletol in 2020, competitors started trying to copy it. The company is fighting back.

Statin labeling should be revised with updated warnings, meta-analysis confirms

Researchers explored data from more than 123,000 patients, noting that dozens of the adverse complications included on current labels can safely be removed.

Esperion settles another lawsuit to keep generic versions of popular drug off shelves

As soon as Esperion Therapeutics gained FDA clearance for Nexletol in 2020, competitors started trying to copy it. The company is fighting back.

Side effect of popular Alzheimer's treatment may actually be a good sign, new PET findings suggest

Amyloid-related imaging abnormality edema is a known side effect of anti-amyloid monoclonal antibody treatments, such as Leqembi and donanemab Kisunla.

After years of implanting left atrial appendage occlusion (LAAO) devices in atrial fibrillation (AFib) patients, an interventional cardiologist with the University of Chicago Medical Center (UChicago Medicine) has developed a new device that could be a more affordable alternative to Boston Scientific’s Watchman and Abbott’s Amplatzer Amulet LAA Occluder.

Cardiologist develops new heart device that uses gel to reduce stroke risk in AFib patients

After years of implanting and studying LAAO devices, an interventional cardiologist with the University of Chicago has designed a new alternative that could reduce the risk of bleeding and save health systems money.

Around the web

Radiology Business

Health system redesigns its imaging management structure around modalities, rather than operating lines